KRITHIGA HASBROOK
Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology COLUMBUS, OH NPI 1215370010
Browse related groups: Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology OH SK Life Science, Inc. All categories
General Payments — all program years on this page
$654.62
- Category: General Payments
- Program years: PY2021–2023
- Record count: 43
- As of (CMS publication): 2026-01-23
Latest program year (PY2023): $120.21 across 7 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2023) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $120.21 | 7 |
By paying entity
Latest program year (PY2023) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| SK Life Science, Inc. | $19.24 | 1 |
| UCB, Inc. | $18.72 | 1 |
| IMPEL PHARMACEUTICALS INC. | $18.68 | 1 |
| Neurelis, Inc. | $17.33 | 1 |
| ABBVIE INC. | $16.33 | 1 |
| EISAI INC. | $15.66 | 1 |
| Marinus Pharmaceuticals, Inc. | $14.25 | 1 |
By program year
Records — PY2023 (7)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1021752991 | UCB, Inc. | $18.72 | 02/14/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1023319015 | Eisai Inc. | $15.66 | 03/23/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1028058139 | Marinus Pharmaceuticals, Inc. | $14.25 | 03/27/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1050919411 | Neurelis, Inc. | $17.33 | 01/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1054731807 | SK Life Science, Inc. | $19.24 | 03/28/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 989372875 | IMPEL PHARMACEUTICALS INC. | $18.68 | 02/01/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 997447257 | ABBVIE INC. | $16.33 | 03/10/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.